Table 2.
AMR and ESBL production in E. coli (n = 1047) and Salmonella (n = 816) isolates that included in this study
| Antimicrobial drugs/enzymes | No. of E. coli (%) | No. of Salmonella (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Pig (n = 697) | Pork (n = 247) | Human (n = 103) | Total (n = 1047) | Pig (n = 169) | Pork (n = 510) | Human (n = 137) | Total (n = 816) | |
| AMP | 623 (89.4) | 200 (81.0) | 62 (60.2) | 885 (84.5) | 148 (87.6) | 395 (77.5) | 89 (65.0) | 632 (77.5) |
| CHP | 423 (60.7) | 83 (33.6) | 17 (16.5) | 523 (50.0) | 25 (14.8) | 147 (28.8) | 83 (60.6) | 255 (31.3) |
| CIP | 220 (31.6) | 8 (3.2) | 7 (6.8) | 235 (22.4) | 0 (0) | 2 (0.4) | 21 (15.3) | 23 (2.8) |
| GEN | 279 (40.0) | 29 (11.7) | 14 (13.6) | 322 (30.8) | 30 (17.8) | 69 (13.5) | 79 (57.7) | 178 (21.8) |
| STR | 453 (65.0) | 114 (46.2) | 11 (10.7) | 578 (55.2) | 109 (64.5) | 323 (63.3) | 123 (89.8) | 555 (68.0) |
| SMZ | 521 (74.7) | 121 (49.0) | 38 (36.9) | 680 (64.9) | 130 (76.9) | 408 (80) | 103 (75.2) | 641 (78.6) |
| TET | 617 (88.5) | 169 (68.4) | 51 (49.5) | 837 (79.9) | 140 (82.8) | 426 (83.5) | 106 (77.4) | 672 (82.4) |
| TMP | 475 (68.1) | 127 (51.4) | 34 (33.0) | 636 (60.7) | 95 (56.2) | 241 (47.3) | 64 (46.7) | 400 (49.0) |
| COL | 160 (23.0) | 15 (6.1) | 0 (0) | 175 (16.7) | 2 (1.2) | 7 (1.4) | 0 (0) | 9 (1.1) |
| ESBLs | 140 (20.1) | 7 (2.8) | 8 (7.8) | 155 (14.8) | 2 (1.2) | 19 (3.7) | 0 (0) | 21 (2.6) |
AMP, ampicillin; CHP, chloramphenicol; CIP, ciprofloxacin; GEN, gentamycin; STR, streptomycin; SMZ, sulphamethoxazole; TET, tetracycline; TMP, trimethoprim; COL, colistin.